Nebraska Medicine Hematology/Oncology

www.nebraskamed.com

 

2018 Pan Pacific Lymphoma Conference
S

How Can We Activate the Anti-tumor Immune Response in Lymphoma?

By 2018 Pan Pacific Lymphoma Conference FEATURING Stephen M. Ansell
By 2018 Pan Pacific Lymphoma Conference FEATURING Stephen M. Ansell
232 views
August 15, 2018
Comments 0
Login to view comments. Click here to Login

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison
Bench to Bedside
08:17

How Can We Activate the Anti-tumor Immune Response in Lymphoma?

2018 Pan Pacific Lymphoma Conference

S. Ansell

232 views
15:08

Immune Evasion and Engagement in Lymphoma: The Mechanisms of Impairm…

2018 Pan Pacific Lymphoma Conference

S. Ansell

165 views
10:59

A Brief Introduction to the Evolving Role of Genomics in NHL with Ca…

2018 Pan Pacific Lymphoma Conference

A. Zelenetz

391 views
11:41

Using Genomic Data Clinically in NHL

2018 Pan Pacific Lymphoma Conference

A. Zelenetz

42 views